跳至主要内容
临床试验/ISRCTN43696201
ISRCTN43696201已完成4 期

Bioresorbable scaffold implantation in STEMI patients

Charles University, University Research programme UNCE 02 and PROGRES Q380 个研究点目标入组 117 人开始时间: 2019年6月7日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
117

研究概览

简要总结

2016 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/27173858 interim analysis (added 05/06/2019) 2014 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/24419808 pilot study (added 05/06/2019) 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32000796 (added 03/02/2020)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. STEMI patients
  • 2. Sign informed consent

排除标准

  • 1. Severe calcification
  • 2. Do not meet specified vessel size
  • 3. Length of the lesion more than 28mm
  • 4. Indication for anticoagulation, cardiogenic shock

研究者

发起方
Charles University, University Research programme UNCE 02 and PROGRES Q38

相似试验